From dermatological conditions toCOVID‐19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy
Dermatologic Therapy | November 21, 2020 | Volume: 34 | Issue: 1 | Pages: No page available
10.1111/dth.14565
| PMID 33219572